Rui Wang

16PUBLICATIONS
80CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyProteomics and intermolecular interactions (excl. medical proteomics)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 03, 2026
Aberrant amino acid-sensing promotes immunotherapy resistance via the inflammatory cytokine-ZBTB5-mTORC1 axis.

Junyu Xiang, Tao Wang, Shuoran Tian

|Mar 11, 2026
Correction: Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.

Tao Wang, Zhong-Yi Qin, Liang-Zhi Wen

|Feb 09, 2026
Metabolic stress conditions dictate MAPKAPK2-dependent efficiency of MEK1/2 inhibition in colorectal carcinoma.

Niti Kumari, Xu Chen, Amber M Baldwin

|Jan 12, 2026
Cancer cachexia: molecular basis and therapeutic advances.

Yuting Tan, Rui Xue, Yuwei Pan

|Sep 25, 2025
TRIM49 Deficiency Stabilizes a Galectin-3/EGR1 Transcriptional Complex That Drives Invasiveness of Gastric Adenocarcinoma.

Zhong-Yi Qin, Lin-Rong Che, Shuoran Tian

|Nov 04, 2024
Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial.

Lei Wang, Mengting Sun, Jinyang Li

Pageof 3

Frequent Collaborators

9 joint publications

Xiuwu Bian

7 joint publications

Xing-Wei Wang

6 joint publications

Qin Liu

2 joint publications

Shiyin Peng